Skip to main content

Daiwa Securities Group Inc.

SEC CIK
0001481045
Latest filing
Jul 31, 2026

ZNTL holding history

Zentalis Pharmaceuticals, Inc. in every 13F filed by Daiwa Securities Group Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ZNTL overviewAll 13F holders of ZNTLFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
15
Since Q1 2021
Holdings of ZNTL by Daiwa Securities Group Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−212−100.0%Sold outHolders
Q3 2024212$1.00K<0.1%00.0%UnchangedHolders
Q2 2024212$1.00K<0.1%00.0%UnchangedHolders
Q1 2024212$3.00K<0.1%00.0%UnchangedHolders
Q4 2023212$3.00K<0.1%00.0%UnchangedHolders
Q3 2023212$4.00K<0.1%00.0%UnchangedHolders
Q2 2023212$6.00K<0.1%00.0%UnchangedHolders
Q1 2023212$4.00K<0.1%00.0%UnchangedHolders
Q4 2022212$4.00K<0.1%00.0%UnchangedHolders
Q3 2022212$5.00K<0.1%00.0%UnchangedHolders
Q2 2022212$6.00K<0.1%+80+60.6%AddedHolders
Q1 2022132$6.00K<0.1%00.0%UnchangedHolders
Q4 2021132$11.0K<0.1%−22−14.3%ReducedHolders
Q3 2021154$10.0K<0.1%+78+102.6%AddedHolders
Q2 202176$4.00K<0.1%00.0%UnchangedHolders
Q1 202176$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.